Shares of West Pharmaceutical Services, Inc. (WST) dropped over 5% after the company announced that its longtime Chief Executive plans to retire.
The stock is currently trading at $235.37, down $12.69 or 5.12%, on the NYSE. It opened at $240.39 after closing the previous session at $248.06. The stock has traded between $187.43 and $322.34 over the past 52 weeks.
West Pharmaceutical said President, CEO and Chair Eric Green has informed the board of his plans to retire once a successor is appointed. The company has engaged an executive recruiting firm to begin the search, with the leadership transition expected in the second half of 2026.
Green has served as CEO since 2015 and became Chair of the Board in 2022. During his tenure, the company said it more than doubled sales and delivered approximately 350% total shareholder return.
The company also reaffirmed its previously issued guidance from February 12, 2026 while beginning the succession process.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.